C

CNS Pharmaceuticals
D

CNSP

5.12000
USD
-0.17
(-3.21%)
مغلق
حجم التداول
5
الربح لكل سهم
-10
العائد الربحي
-
P/E
-0
حجم السوق
7,482,619
أصول ذات صلة المقالات
المزيد

العنوان: CNS Pharmaceuticals Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.